Identification and analysis of key genes in osteosarcoma using bioinformatics

Area of Science:

• Oncology
• Molecular Biology
• Bioinformatics

Background:

• Osteosarcoma (OS) is an aggressive bone cancer.
• Understanding the molecular mechanisms driving OS metastasis is crucial for developing effective treatments.

Purpose of the Study:

• To identify and analyze key genes associated with OS metastasis.
• To investigate the role of epidermal growth factor receptor (EGFR) in OS progression.

Main Methods:

• Differential gene expression analysis of metastatic versus non-metastatic OS cell lines using the GSE49003 dataset.
• Construction and analysis of a protein-protein interaction (PPI) network for differentially expressed genes (DEGs).
• Functional and pathway enrichment analyses, identification of transcription factors (TFs) and CpG islands in the EGFR promoter region.

Main Results:

• Identified 323 DEGs between metastatic and non-metastatic OS samples.
• Epidermal growth factor receptor (EGFR) was identified as a highly interconnected protein in the PPI network, enriched in cytoskeleton organization and focal adhesion pathways.
• Several TFs (e.g., EGR1, NF-κB, STAT3, MYC) and CpG islands were found in the EGFR promoter region, suggesting potential regulatory roles.

Conclusions:

• EGFR plays a significant role in OS progression.
• TF binding and CpG island methylation in the EGFR promoter may regulate its expression and contribute to OS metastasis.
• These findings provide potential therapeutic targets for osteosarcoma.